Adjuvant Osimertinib for Resected EGFR-Mutated Stage IB-IIIA Non-Small-Cell Lung Cancer: Updated Results From the Phase III Randomized ADAURA Trial
AstraZeneca
Roy S Herbst; Yi-Long Wu; Thomas John; Christian Grohe; Margarita Majem; Jie Wang; Terufumi Kato; Jonathan W Goldman; Konstantin Laktionov; Sang-We Kim; Chong-Jen Yu; Huu Vinh Vu; Shun Lu; Kye Young Lee; Guzel Mukhametshina; Charuwan Akewanlop; Filippo de Marinis; Laura Bonanno; Manuel Domine; Frances A Shepherd; Damien Urban; Xiangning Huang; Ana Bolanos; Marta Stachowiak; Masahiro Tsuboi
Oncology Biometrics, AstraZeneca, Cambridge, United Kingdom.